Application of autonomous extended infusion therapy systems in treatment of patients with hemoblastoses. Experience of the Oncohematology Division of the Clinical Hospital “Lapino”
Yu. E. Ryabukhina,
P. A. Zeynalova,
F. M. Abbasbeyli,
O. L. Timofeeva,
T. T. Valiev,
A. G. Zhukov,
N. A. Kupryshina https://doi.org/10.17650/2782-3202-2023-3-1-61-67
Abstract
Use of microinfusion elastomeric pumps for extended administration of antitumor drugs improves patients’ quality of life during prolonged cyclic treatment because of the absence of venous complications and infusion allergic reactions during administration of cytostatic agents and targeted drugs.
About the Authors
Yu. E. Ryabukhina
Clinical Hospital “Lapino” of the “Mother and Child” Group of companies
Russian Federation
Russian Federation
111 1st Uspenskoe Shosse, Lapino, Moscow region 143081
P. A. Zeynalova
Clinical Hospital “Lapino” of the “Mother and Child” Group of companies; I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)
Russian Federation
Russian Federation
111 1st Uspenskoe Shosse, Lapino, Moscow region 143081
Bld. 2, 8 Trubetskaya St., Moscow 119991
F. M. Abbasbeyli
Clinical Hospital “Lapino” of the “Mother and Child” Group of companies
Russian Federation
Russian Federation
111 1st Uspenskoe Shosse, Lapino, Moscow region 143081
O. L. Timofeeva
Clinical Hospital “Lapino” of the “Mother and Child” Group of companies
Russian Federation
Russian Federation
111 1st Uspenskoe Shosse, Lapino, Moscow region 143081
T. T. Valiev
I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)
Russian Federation
Russian Federation
Bld. 2, 8 Trubetskaya St., Moscow 119991
A. G. Zhukov
Clinical Hospital “Lapino” of the “Mother and Child” Group of companies
Russian Federation
Russian Federation
111 1st Uspenskoe Shosse, Lapino, Moscow region 143081
N. A. Kupryshina
N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia
Russian Federation
Russian Federation
24 Kashirskoe Shosse, Moscow 115478
References
1. Kreidieh F.Y., Moukadem H.A., El Saghir N.S. Overview, prevention and management of chemotherapy extravasation. World J Clin Oncol 2016;7(1):87–97. DOI: 10.5306/wjco.v7.i1.87
2. Skryabina E.A., Dunn T.S. Disposable infusion pumps. Am J Health Syst Pharm 2006;63(13):1260–8. DOI: 10.2146/ajhp050408
3. Evans J.M., Qiu M., MacKinnon M. et al. A multi-method review of home-based chemotherapy. Eur J Cancer Care (Engl) 2016;25(5):883–902. DOI: 10.1111/ecc.12408
4. Giuliano K.K., Penoyer D., Mahuren R.S., Bennett M. Intravenous smart pumps during actual clinical use: a descriptive comparison of primary and secondary infusion practices. J Infus Nurs 2021;44(3):128–36. DOI: 10.1097/NAN.0000000000000415
5. Mann J.R., Abrams L.D., Deeble T.J., Stuart J. Prolonged intermittent cytotoxic therapy in children using a microinfusion pump. Lancet 1970;2(7683):1116–7. DOI: 10.1016/s0140-6736(70)92301-9
6. Yu C.H., Jou S.T., Su Y.H. et al. Clinical impact of minimal residual disease and genetic subtypes on the prognosis of childhood acute lymphoblastic leukemia. Cancer 2023;129(5):790–802. DOI: 10.1002/cncr.34606
7. Robinson H.R., Qi J., Cook E.M. et al. A CD19/CD3 bispecific antibody for effective immunotherapy of chronic lymphocytic leukemia in the ibrutinib era. Blood 2018;132(5):521–32. DOI: 10.1182/blood-2018-02-830992
8. Locatelli F., Zugmaier G., Rizzari C. et al. Effect of blinatumomab vs chemotherapy on event-free survival among children with high-risk first-relapse B-cell acute lymphoblastic leukemia: a randomized clinical trial. Jama 2021;325(9):843–54. DOI: 10.1001/jama.2021.0987
9. Abdurakhmanov D.T., Abuzarova G.R., Ageeva T.A. et al. Russian clinical guidelines for the diagnosis and treatment of lymphoproliferative diseases. Ed. by I.V. Poddubnaya, V.G. Savchenko. Moscow, 2018. 470 p. (In Russ.).
10. Buidenok Yu.V. Recommendations for the prevention and treatment of the effects of extravasation of antitumor drugs. Prakticheskiye rekomendatsii RUSSCO = Malignant tumours: Practical recommendations of RUSSCO 2021;11(3s2):156–66. (In Russ.). DOI: 10.18027/2224-5057-2021-11-3s2-48
11. Babicheva L.G., Tumyan G.S., Osmanov E.A. et al. Follicular lymphoma. Sovremennaya oncologiya = Journal of Modern Oncology 2020;22(2):34–51. DOI: 10.26442/18151434.2020.2.200131
12. Dimopoulos M.A., Moreau P., Terpos E. et al. Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2021;32(3):309–22. DOI: 10.1016/j.annonc.2020.11.014
Review
For citations:
Ryabukhina Yu.E., Zeynalova P.A., Abbasbeyli F.M., Timofeeva O.L., Valiev T.T., Zhukov A.G., Kupryshina N.A. Application of autonomous extended infusion therapy systems in treatment of patients with hemoblastoses. Experience of the Oncohematology Division of the Clinical Hospital “Lapino”. MD-Onco. 2023;3(1):61-67. (In Russ.) https://doi.org/10.17650/2782-3202-2023-3-1-61-67
Views:
142
Email this article 